Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alane Pereira Cortez

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|August 23, 2015
4-Nerolidylcatechol analogues as promising anticancer agentsAlane Pereira Cortez, Renato Ivan de Ávila, Carla Rosane Mendanha da Cunha, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|February 18, 2014
The clinicopathologic significance of the expression of HLA-G in oral squamous cell carcinomaAndréia Souza Gonçalves, Isabela Jubé Wastowski, Lucas Raineri Capeletti, et al.
Fundamental & Clinical Pharmacology|February 4, 2020
Small-molecule MDM2 inhibitor LQFM030-induced apoptosis in p53-null K562 chronic myeloid leukemia cellsHigor de Oliveira Ribeiro, Alane Pereira Cortez, Renato Ivan de Ávila, et al.
Pharmaceutical Biology|June 24, 2017
4-Nerolidylcatechol: apoptosis by mitochondrial mechanisms with reduction in cyclin D1 at G0/G1 stage of the chronic myelogenous K562 cell linePolyana Lopes Benfica, Renato Ivan de Ávila, Bruna Dos Santos Rodrigues, et al.
European Journal of Medicinal Chemistry|February 5, 2013
4-Nerolidylcatechol and its synthetic analogues: antioxidant activity and toxicity evaluationCarla Rosane Mendanha da Cunha, Sebastião Antônio Mendanha Neto, Claudio Carlos da Silva, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 20, 2017
A novel chalcone derivative, LQFM064, induces breast cancer cells death via p53, p21, KIT and PDGFRABruna Lannuce Silva Cabral, Artur Christian Garcia da Silva, Renato Ivan de Ávila, et al.
Life Sciences|December 27, 2017
LQFM030 reduced Ehrlich ascites tumor cell proliferation and VEGF levelsMariana Flavia da Mota, Flávio Silva de Carvalho, Renato Ivan de Ávila, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|August 23, 2015
4-Nerolidylcatechol analogues as promising anticancer agentsAlane Pereira Cortez, Renato Ivan de Ávila, Carla Rosane Mendanha da Cunha, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|February 18, 2014
The clinicopathologic significance of the expression of HLA-G in oral squamous cell carcinomaAndréia Souza Gonçalves, Isabela Jubé Wastowski, Lucas Raineri Capeletti, et al.
Fundamental & Clinical Pharmacology|February 4, 2020
Small-molecule MDM2 inhibitor LQFM030-induced apoptosis in p53-null K562 chronic myeloid leukemia cellsHigor de Oliveira Ribeiro, Alane Pereira Cortez, Renato Ivan de Ávila, et al.
Pharmaceutical Biology|June 24, 2017
4-Nerolidylcatechol: apoptosis by mitochondrial mechanisms with reduction in cyclin D1 at G0/G1 stage of the chronic myelogenous K562 cell linePolyana Lopes Benfica, Renato Ivan de Ávila, Bruna Dos Santos Rodrigues, et al.
European Journal of Medicinal Chemistry|February 5, 2013
4-Nerolidylcatechol and its synthetic analogues: antioxidant activity and toxicity evaluationCarla Rosane Mendanha da Cunha, Sebastião Antônio Mendanha Neto, Claudio Carlos da Silva, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 20, 2017
A novel chalcone derivative, LQFM064, induces breast cancer cells death via p53, p21, KIT and PDGFRABruna Lannuce Silva Cabral, Artur Christian Garcia da Silva, Renato Ivan de Ávila, et al.
Life Sciences|December 27, 2017
LQFM030 reduced Ehrlich ascites tumor cell proliferation and VEGF levelsMariana Flavia da Mota, Flávio Silva de Carvalho, Renato Ivan de Ávila, et al.
Pageof 1